Xora

Summit Nanotech Corporation is a business-to-business company based in Calgary, Canada, founded in 2018. It specializes in nanotechnology to develop innovative solutions for lithium extraction, aiming to optimize operations for lithium producers while minimizing environmental impact. The company's patented extraction technology is designed to deliver economically competitive, battery-grade lithium, addressing the industry's demand for sustainable practices. By focusing on modular commercial systems, Summit Nanotech seeks to upscale and commercialize its advanced concepts in lithium extraction, positioning itself as a leader in the energy development sector.

SpeQtral Pte Ltd specializes in developing space-based quantum key distribution (QKD) networks aimed at providing secure encryption key delivery globally. Founded in 2017 and headquartered in Singapore, with an additional office in the United States, the company leverages technologies originating from the Centre for Quantum Technologies at the National University of Singapore. SpeQtral's team has successfully demonstrated a quantum light source on a cubesat, which positions them uniquely in the field of quantum communication. By utilizing the principles of quantum physics, SpeQtral aims to create encryption methods that ensure secure communications with forward security, addressing the growing demand for robust cybersecurity solutions in the commercial sector.

SpeQtral Pte Ltd specializes in developing space-based quantum key distribution (QKD) networks aimed at providing secure encryption key delivery globally. Founded in 2017 and headquartered in Singapore, with an additional office in the United States, the company leverages technologies originating from the Centre for Quantum Technologies at the National University of Singapore. SpeQtral's team has successfully demonstrated a quantum light source on a cubesat, which positions them uniquely in the field of quantum communication. By utilizing the principles of quantum physics, SpeQtral aims to create encryption methods that ensure secure communications with forward security, addressing the growing demand for robust cybersecurity solutions in the commercial sector.

Allozymes is a privately-held backing company that offers non-financial services.

Nuevocor is a preclinical-stage biopharmaceutical company dedicated to the development of gene therapy-based treatments aimed at restoring cardiac function in patients with cardiovascular diseases. The company's research focuses on genetic cardiomyopathies that involve abnormal mechanobiology. By modulating mechanical force transduction, Nuevocor's innovative approaches seek to address the underlying mechanisms of these diseases, ultimately enabling healthcare providers to improve cardiac function in affected individuals.